Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial

被引：0
|
作者：
Sharma, A. [1 ]
Inzucchi, S. E. [2 ]
Testani, J. [3 ]
Ofstad, A. P. [4 ]
Fitchett, D. [5 ]
Mattheus, M. [6 ]
Verma, S. [7 ]
Zannad, F. [8 ]
Wanner, C. [9 ]
Kraus, B. J. [10 ]
机构：
[1] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[4] Boehringer Ingelheim Norway KS, Asker, Norway
[5] Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON, Canada
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[7] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON, Canada
[8] Univ Lorraine, CHRU Nancy, Ctr Invest Clin Plurithemat 1433, INSERM 1116,FCRIN,INI,CRCT, Nancy, France
[9] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany
[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [21] Empagliflozin and Cardiorenal Outcomes in Patients with Nonproteinuric Kidney Disease in the EMPA-REG OUTCOME Trial
    Inzucchi, Silvio E.
    Zinman, Bernard
    George, Jyothis
    Mattheus, Michaela
    von Eynatten, Maximilian
    Wanner, Christoph
    Hauske, Sibylle
    DIABETES, 2019, 68
  • [22] Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes
    Dar, Moahad S.
    Wanner, Christoph
    Marx, Nikolaus
    Ofstad, Anne Pernille
    Mattheus, Michaela
    Kaspers, Stefan
    Beg, Sami A.
    DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1372 - 1384
  • [23] Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial
    Vaduganathan, Muthiah
    Inzucchi, Silvio E.
    Sattar, Naveed
    Fitchett, David H.
    Ofstad, Anne Pernille
    Brueckmann, Martina
    George, Jyothis T.
    Verma, Subodh
    Mattheus, Michaela
    Wanner, Christoph
    Zinman, Bernard
    Butler, Javed
    DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2775 - 2784
  • [24] Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME®
    Bernard Zinman
    Silvio E. Inzucchi
    Christoph Wanner
    Uwe Hehnke
    Jyothis T. George
    Odd Erik Johansen
    David Fitchett
    Diabetologia, 2018, 61 : 1522 - 1527
  • [25] MEDIATORS OF THE EMPAGLIFLOZIN TREATMENT EFFECT ON KIDNEY OUTCOMES IN THE EMPA-REG OUTCOME TRIAL
    Jardine, M.
    Wanner, C.
    Nangaku, M.
    Kraus, B.
    Zinman, B.
    Mattheus, M.
    Hantel, S.
    Schumacher, M.
    Ohneberg, K.
    Schmoor, C.
    Inzucchi, S. E.
    NEPHROLOGY, 2021, 26 : 19 - 19
  • [26] Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
    Ferreira, Joao Pedro
    Verma, Subodh
    Fitchett, David
    Ofstad, Anne Pernille
    Lauer, Sabine
    Zwiener, Isabella
    George, Jyothis
    Wanner, Christoph
    Zinman, Bernard
    Inzucchi, Silvio E.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [27] EMPA-REG OUTCOME: cardiovascular outcome trials in diabetes come of age
    Krentz, Andrew J.
    CARDIOVASCULAR ENDOCRINOLOGY, 2015, 4 (04): : 115 - 116
  • [28] Empagliflozin facilitates sustained insulin dose reductions in patients with type 2 diabetes and cardiovascular disease: the EMPA-REG OUTCOME trial
    Vaduganathan, M.
    Sattar, N.
    Fitchett, D.
    Ofstad, A.
    Brueckmann, M.
    George, J. T.
    Verma, S.
    Mattheus, M.
    Wanner, C.
    Inzucchi, S. E.
    Zinman, B.
    Butler, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S275 - S275
  • [29] Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
    João Pedro Ferreira
    Subodh Verma
    David Fitchett
    Anne Pernille Ofstad
    Sabine Lauer
    Isabella Zwiener
    Jyothis George
    Christoph Wanner
    Bernard Zinman
    Silvio E. Inzucchi
    Cardiovascular Diabetology, 19
  • [30] Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
    Waijer, Simke W.
    Xie, Di
    Inzucchi, Silvio E.
    Zinman, Bernard
    Koitka-Weber, Audrey
    Mattheus, Michaela
    von Eynatten, Maximillian
    Inker, Lesley A.
    Wanner, Christoph
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
12345